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Abstract: Chronic pain can be associated with movement abnormalities. The primary motor cortex
(M1) has an essential role in the formulation and execution of movement. A number of changes in
M1 function have been reported in studies of people with chronic pain. This review systematically
evaluated the evidence for altered M1 structure, organization, and function in people with chronic
pain of neuropathic and non-neuropathic origin. Database searches were conducted and a modified
STrengthening the Reporting of OBservational studies in Epidemiology checklist was used to assess
the methodological quality of included studies. Meta-analyses, including preplanned subgroup analy-
ses on the basis of condition were performed where possible. Sixty-seven studies (2,290 participants)
using various neurophysiological measures were included. There is conflicting evidence of altered M1
structure, organization, and function for neuropathic and non-neuropathic pain conditions. Meta-
analyses provided evidence of increased M1 long-interval intracortical inhibition in chronic pain
populations. For most measures, the evidence of M1 changes in chronic pain populations is inconclusive.
Perspective: This review synthesizes the evidence of altered M1 structure, organization, and func-
tion in chronic pain populations. For most measures, M1 changes are inconsistent between studies
and more research with larger samples and rigorous methodology is required to elucidate M1 changes
in chronic pain populations.
© 2017 The Author(s). Published by Elsevier Inc. on behalf of the American Pain Society. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Chronic pain conditions such as low back pain (LBP),neck pain, and knee osteoarthritis (OA) are leadingcauses of disability globally107 and are associated
with significant and rising health care and socioeco-
nomic costs.50 Despite this, effective treatment remains
elusive.
People with chronic pain conditions commonly present
with abnormalities of movement. For example, exces-
sive finger flexion has been reported during grip release
in chronic lateral elbow pain, greater hip adduction and
internal rotation during stair climbing in lateral hip pain,
and delayed onset of trunk muscle activation during
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arm elevation in recurrent LBP.3,33,97 As a result, rehabili-
tation to target movement dysfunction is a treatment for
musculoskeletal pain. However, treatment success with
this approach is limited1,71 and there is debate regard-
ing the type, quantity, and timing of interventions needed
to effectively target movement dysfunction in chronic
musculoskeletal pain or indeed whether such an ap-
proach is warranted.2,30,31
The physiological basis of movement dysfunction in pain
is poorly understood. The primary motor cortex (M1) has
an essential role in the formulation and execution of
movement and is likely to have a role in movement ab-
normalities. Indeed, a recent systematic review provided
evidence of reduced M1 output (ie, corticospinal excit-
ability) in response to acute muscle pain that may
represent an adaptive mechanism to protect against
further pain or injury.9 Similarly, studies investigating M1
in experimental models of progressively developing, sus-
tained muscle pain show altered M1 organization
(increased representations of painful muscles) and func-
tion (reduced M1 inhibition) 4 days after pain onset.77
Studies have reported that changes in M1 structure, or-
ganization, and function may also be present when pain
becomes chronic. For example, associations have been re-
ported between the severity of pain and/or the degree
of movement dysfunction in chronic musculoskeletal dis-
orders such as low back, elbow, and patellofemoral pain
and reorganization of the M1 representation (ie, greater
representational overlap, reduced number of discrete
peaks) of muscles in the region of pain.78,79,94 However,
it is unclear whether M1 reorganization presents in other
chronic pain conditions and whether it can be observed
via different neurophysiological methods.
Previous reviews examining changes in M1 in chronic
pain have been restricted to specific pain conditions or
by the neurophysiological method used to assess M1. For
instance, a systematic review revealed limited evidence
for bilateral M1 disinhibition in complex regional pain
syndrome (CRPS) of the upper limb.20 Whether similar al-
terations in M1 are present in other forms of chronic pain
is unknown. Indeed, it has been suggested that M1 dis-
inhibition may occur in chronic neuropathic but not
chronic nociceptive pain.82 A second systematic review re-
ported similar findings of disinhibition across a range of
chronic pain conditions (including migraine) but was re-
stricted to data obtained using transcranial magnetic
stimulation (TMS).65 The integration of information on
M1 structure, organization, and function across 1) a range
of neuropathic and non-neuropathic conditions, and 2)
using a range of complementary neurophysiological tech-
niques, is necessary to provide comprehensive information
on whether M1 is altered in chronic pain. This informa-
tion is timely because of the range of treatment
techniques being tested that target the M1 in chronic
pain.12,56,74,80
The aim of this review was to systematically evaluate
the evidence of altered M1 structure, organization, and
function in chronic pain conditions of neuropathic and
non-neuropathic origin across a range of neurophysi-
ological methods.
Methods
The protocol of this review was prospectively regis-
tered with the International Prospective Register of
Systematic Reviews (registration number CRD42015014823)
and has been published elsewhere.13 This review is re-
ported following the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses statement.46
Search Strategy
The search was conducted in 5 electronic databases
(PubMed, MEDLINE, Embase, PsychINFO, and CINAHL)
from inception to February 2017, using key words and
medical subject headings terms related to chronic pain
and M1 organization/function (Supplementary
Appendix 1). The reference list of eligible studies and rel-
evant reviews were manually searched for additional
articles.
Eligibility Criteria
Inclusion criteria were: 1) full text studies published in
English, including in press or accepted studies, 2) adult
(aged older than 18 years) humans with non-neuropathic
or neuropathic pain, 3) duration of pain >3 months,64 4)
investigated and reported measures of the organiza-
tion and/or function of the M1 (regardless of the
anatomical or functional definition used) using TMS, mag-
netic resonance imaging (MRI), electroencephalography
(EEG), magnetoencephalography (MEG), magnetic
Table 1. Summary of M1 Structural, Organizational, and Functional Constructs and Their
Associated Neurophysiological Methods and Outcome Measures
M1 STRUCTURE M1 ORGANIZATION M1 FUNCTION
Neurophysiological methods
and outcome measures





TMS: M1 representation (map
volume, CoG of M1
representation)
TMS: corticospinal excitability (rMT, aMT, MEP
amplitude and latency, CSP); ICF/
intracortical inhibition
EEG: cerebrocortical motor activity




Abbreviation: rMT, resting motor threshold.
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resonance spectroscopy (MRS), or positron emission to-
mography (PET; Table 1). Studies were excluded if: 1)
included participants presented chronic pain associated
with neurological disorders, cancer, or visceral pain, or
2) the study did not include a healthy control group or
used the unaffected limb or body side as a control. Cross-
sectional or prospective studies, including case-control and
randomized controlled trials that provided baseline data
with information relevant to the review objective and
that met the eligibility criteria, were included.
Study Selection
Search results were imported into Endnote X7 (Clarivate
Analytics, Philadelphia, PA). After removing duplicates,
2 reviewers independently screened titles and abstracts
of all studies to remove those not relevant to the review
objective. The full text of all remaining studies were re-
trieved and evaluated according to the eligibility criteria.
If there was uncertainty or disagreement, a third re-
viewer was consulted.
Data Extraction
Two independent reviewers extracted the following
data: pain condition, country of origin, study design and
setting, inclusion/exclusion criteria, source of partici-
pants, sample size, participant demographic characteristics,
duration and severity of chronic pain, neurophysiologi-
cal methods, specifics of the investigative model, type and
location of stimulation, and outcomes (ie, M1 excitabil-
ity, representation, reactivity, neurochemical or glucose
metabolism). Any disagreements were resolved in con-
sensus with a third reviewer. If data were missing, authors
were contacted a maximum of 3 times, after which the
data were considered irretrievable.
Quality and Risk of Bias Assessment
Study quality and risk of bias were assessed by 2 in-
dependent reviewers using a modified version of the
STrengthening the Reporting of OBservational studies in
Epidemiology (STROBE) statement for cross-sectional and
cohort studies.67,103,104 Disagreements were resolved by con-
sensus with a third reviewer. The modified STROBE
statement investigated potential for bias in 5 domains:
1) source of participants, 2) participant selection, 3) meth-
odology, 4) statistical analysis, and 5) funding
(Supplementary Appendix 2). Each domain would be al-
located 1 point if the risk of bias was low and no point
if the risk of bias was considered high. The maximum score
possible was 5 points. For studies using TMS, an addi-
tional methodological quality assessment was undertaken
using an adapted version of the TMS methodological
checklist.14 Two items that were not relevant for this
review were removed from the checklist (item 22—time
between days of testing—and item 30—size of the un-
conditioned motor evoked potential [MEP] controlled).
Each domain that was reported (r) and/or controlled (c)
was allocated 1 point. In total, the maximum score pos-
sible for the reported and controlled items of the TMS
methodological checklist were, respectively, 26 and 25 for
single-pulse TMS, and 29 and 28 for paired-pulse TMS.
The ratio of the summed score relative to the maximum
score for the reported (r/[26 or 29] × 100) and con-
trolled (c/[25 or 28] × 100) items was calculated. The
median percentage for the reported and controlled items
was then calculated. TMS studies received 1 point in the
methodology category of the modified STROBE state-
ment if the percentage of reported and controlled items
were both greater than the median value.
Data Synthesis
Meta-analyses were performed to aggregate the data
from TMS studies. Because of increased heterogeneity in
the methodology of included studies, a narrative syn-
thesis was used to summarize the findings of studies using
other neurophysiological methods.84 TMS outcome mea-
sures (resting and active motor threshold [aMT], MEP
amplitude and latency, cortical silent period (CSP), map
volume, intracortical inhibition and facilitation) were
pooled and separate meta-analyses were performed using
RevMan version 5.3 (The Nordic Cochrane Centre, The Co-
chrane Collaboration, Copenhagen). Cohen d effect sizes
were used to analyze effect estimates (d ≤.2, small; .5,
moderate; ≥.8, large).16 Meta-analyses were performed
using a random effects model when data from at least
2 studies addressing that outcome were accessible. Sta-
tistically significant heterogeneity was identified using
the χ2 test and was considered when χ2 P < .10. The I2 sta-
tistic was used to evaluate the degree of heterogeneity.
Substantial heterogeneity was considered present when
I2 > 50%.35 Meta-analyzed data are presented as effect
estimates (standardized mean difference [SMD] with 95%
confidence intervals [CIs]).
Subgroup and Sensitivity Analysis
Preplanned subgroup analyses were conducted accord-
ing to the type of musculoskeletal condition where
significant heterogeneity was identified. The median value
of the modified STROBE statement score of the TMS
studies was used as a cutoff point to divide studies into
either low or high risk of bias groups. The influence of
high risk of bias studies was examined by rerunning the
analysis with those studies excluded.
Results
The initial search identified 5,028 records, from which
120 full text articles were retrieved to assess eligibility.
Sixty-nine studies met the inclusion criteria in the review.
The authors of 14 studies were contacted to request ad-
ditional data pertaining to M1 function. Two studies were
excluded as a result of unsuccessful attempts to acquire
these data.18,106 Thus, a total of 67 studies were in-
cluded in this review. The study flow chart can be seen
in Fig 1.
Study Characteristics
The included studies encompassed 7 neurophysiologi-
cal methods: TMS (n = 35 studies), functional MRI (fMRI;
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n = 16 studies), MRI (n = 6 studies), MEG (n = 3 studies),
MRS (n = 3 studies), EEG (n = 1 study), and PET (n = 1
study). Two studies investigated functional as well as struc-
tural MRI changes.95,101 In total, the included studies
involved 1,248 chronic pain (20 different pain condi-
tions) and 1,042 healthy participants. CRPS (n = 16 studies)
and LBP (n = 16 studies) were the most frequently inves-
tigated conditions.
Five studies investigated 2 or more chronic pain
conditions.11,72,73,75,82 Participant sex (n = 4 studies) and age
(n = 3 studies), pain intensity (n = 22 studies), and the du-
ration of the pain (n = 7 studies) were not reported by
some of the included studies. The characteristics of in-
cluded studies are summarized in Tables 2 and 3.
Quality and Risk of Bias Within Studies
The average score for the methodological quality as-
sessment was 3.1 of 5 (range = 1–5; Table 4), with 50
studies presenting a score of ≥3. For the TMS method-
ology checklist, the average score for the reported items
was 64.8% (SD = 13) and for the controlled items 61.1%
(SD = 13.8). All studies reported and controlled position
and contact of electromyography electrodes and stimu-
lation intensity. All studies that used paired-pulse
paradigms (n = 16) reported the intensity of the test and
conditioning pulse and the interstimulus interval. Par-
ticipant age and sex, although reported, were not
controlled. Items that were not consistently reported or
controlled were: previous motor activity of the muscle
to be tested, level of relaxation of the muscles other than
those being tested, pulse shape, and participants’ pre-
scribed medication.
Is There Evidence of Altered M1
Function, Organization, and Structure in
Chronic Pain?
We were unable to conduct meta-analyses of these data
because of the heterogeneity of methodology across the
included studies. Furthermore, the effect size of the dif-
ferences between the pain and healthy participants were
not reported in these studies.
In neuropathic pain, 3 studies reported statistically sig-
nificant (P < .05) increases in M1 activation/connectivity
in neuropathic pain populations from regional cerebral
blood flow (rCBF)47 (cluster level corrected P < .05, n = 22
participants, quality score = 2) and blood oxygen level-
dependent (BOLD) contrast studies (n = 42 participants,
quality score = 495; n = 19 participants, quality score = 462).
Voxel-based morphometry (VBM) imaging showed 12%
to 13% increase in bilateral M1 cortical thickness in
Records identified through 
database searching
(n = 7381)
Additional records identified 
through other sources
(n = 41)











- Not musculoskeletal 
or neuropathic pain 
(n = 29)
- No data on M1
function or 
structure (n = 20)
- No healthy control 
data (n = 4)
Studies included in 
systematic review
(n = 67)
Studies included in meta-
analysis
(n = 35)
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram of the screening and inclusion of
studies.
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Table 2. Characteristics of Studies using TMS
REFERENCE CONDITION COUNTRY
CHRONIC PAIN PARTICIPANTS HEALTHY PARTICIPANTS











(M/F), N AGE, YEARS








NA NA 13 (NA) 49.1 ± 5
(SEM)














CRPS I: hand Germany 25 (9/16) 49.1 ± 13.8 26.1 ± 47
Months
NA 20 (10/10) 20 to
78 (95%
CI)










Strutton et al91 Chronic sciatica United
Kingdom








On et al63 Patello-femoral
pain
Turkey 13 (0/13) 25 ± 8.1
(SEM)
3.46 ± 1.9 Years
(SEM)
NA 13 (0/13) 25.1 ± 7.4
(SEM)









Eisenberg et al21 CRPS I: hand;
CRPS I: foot









14 (10/4) 30.9 ± 12.7 Figure of 8








Krause et al43 CRPS I: hand Germany 12 (2/10) 55.9 ± 15.6 NA NA 10 (NA) 42.4 Figure of 8




Long extensor muscle rMT, MEP
amplitude, CSP
Strutton et al92 LBP United
Kingdom




Erector spinae aMT, MEP latency,
CSP
Krause et al44 CRPS: hand Germany 14 (4/10) 37 (17–72) >6 Months NA 10 38 (24–63) Figure of 8
coil (7 cm) on M1
Single pulse,
monophasic*
Long extensor muscle rMT, MEP
amplitude, map
volume
Turton et al99 CRPS I: hand United
Kingdom
8 (1/7) 45 ± 13 6.6 ± 4.9 Years 6.3 ± 1.4 8 (1/7) 45 ± 13 Figure of 8







Tsao et al97 LBP Australia 11 (5/6) 24 ± 7 5.6 ± 4.2 Years 5.5 ± 2 11 (4/7) 23 ± 3 Figure of 8
coil (7 cm) and
double cone






























CHRONIC PAIN PARTICIPANTS HEALTHY PARTICIPANTS











(M/F), N AGE, YEARS
Turgut et al98 Diabetic
neuropathic
pain









Mhalla et al57 Fibromyalgia France 21 (0/21) 52.2 ± 10.4 14.1 ± 11.9
Years





























Clark et al15 LBP United
States




cone coil on vertex
Single pulse,
NA
Erector spinae MEP amplitude
Schwenkreis
et al83










Tsao et al96 LBP Australia 9 (4/5) 25 ± 3.4 3.6 ± 2.3 Years 4.7 ± 1.1 11 (5/6) 24 ± 5 Figure of 8








LBP Canada 13 (6/7) 53.7 ± 7.4 16 ± 10 Years 2.9 ± 2.5 9 (4/5) 48.7 ± 6.8 Double cone










Vallence et al105 Chronic tension
type headache
Australia 11 (5/6) 35 ± 13.2 NA NA 18 (7/11) 28 ± 8
(unclear)








Kittelson et al41 OA knee United
States
17 (8/9) 63.9 ± 1.8
(SEM)
NA NA 20 (10/10) 58.3 ± 2.5
(SEM)





Vastus lateralis rMT, MEP
amplitude, SICI,
ICF
Marker et al51 Neck pain United
States
9 (2/7) 42.4 ± 11 >12 Months 1.7 ± 1.4 8 (4/4) 31.5 ± 14.5 Figure of 8













29 ± 7; 27 ± 6 >3 Months 1.7 ± .6
1.5 ± .6




















L3 and L5 erector
spinae
Map volume
























CHRONIC PAIN PARTICIPANTS HEALTHY PARTICIPANTS











(M/F), N AGE, YEARS
Schabrun et al79 Lateral
epicondylalgia
Australia 11 (5/6) 44 ± 11 9 ± 6 Months 2.7 ± 2 11 (5/6) 42 ± 11 Figure of 8











CRPS I: hand Netherlands 12 (2/10) 51 ± 9.5 88 ± 26.9
Months








Burns et al8 Lateral
epicondylalgia
Australia 14 (4/10) 41.5 ± 9.9 37.3 ± 74.8
Months



















NA 7.2 ± 2.2;
7.9 ± 1.9;
6.3 ± 2.2










LBP Canada 35 (20/15) 38 ± 14.6 65.8 ± 72.8
Months










LBP Canada 11 (6/5) 33.8 ± 12.5 NA 2 ± 1.9 13 (6/7) 37.6 ± 12.5 Double cone





















8 (7/1) 26 (18–37)
(median)
Double cone





Tarrago et al93 OA knee Brazil 21 (0/21) 64.5 ± 7.72 6.73 ± 2.53
Years









Morgante et al60 CRPS I: hand United
States
10 (1/9) 48.2 ± 5.5 (SE) 11.3 ± 1.8
Months (SE)
8.1 ± .73 10 (1/9) 48.3 ± 12.5
(SE)









Parker et al66 OA hand New
Zealand
23 (6/17) 72 ± 6 13.5 ± 13.1
years










Te et al94 Patello-femoral
pain








Abbreviations: M, male; F, female; SEM, standard error of the mean; NA, not available; rMT, resting motor threshold; SE, standard error.
NOTE. Values are mean ± SD unless otherwise stated.















Table 3. Characteristics of Included Studies Using Other Neurophysiological Methods
REFERENCE CONDITION COUNTRY










Cook et al17 Fibromyalgia United States 9 (0/9) 37 ± 5 NA 1.03 ± .7 9 (0/9) 35 ± 3 fMRI Heat pain on left thenar
eminence
BOLD at 1.5 T
Napadow et al62 Carpal tunnel
syndrome
United States 10 (4/6) 51.1 (31–60) 4 months to 10
years
NA 9 (3/6) 46.9 (32–59) fMRI Innocuous electrical
stimulation to digit 2, 3,
and 5
BOLD at 3 T
Maihöfner et al49 CRPS I: hand Germany 12 (2/10) 41.2 ± 2.5 (SEM) 52.2 ± 32 weeks
(SEM)
3.9 ± .8 (SEM) 12 (2/10) 43.2 ± 2.5 (SEM) fMRI Finger tapping task BOLD at 1.5 T
Gieteling et al28 CRPS I: hand with
dystonia
Netherlands 8 (1/7) 46.4 ± 6 NA NA 17 (2/15) 42.9 ± 9.2 fMRI Imagining and performing
wrist flexion/extension
BOLD at 3 T
Kobayashi et al42 LBP Japan 8 (5/3) 33 (22–44) >3 Months NA 8 (8/0) 29 (22–42) fMRI Lumbar mechanical
compression
BOLD at 3 T




4.8 (95% CI =
3.8–5.9)
16 (5/11) 46.7 (95% CI =
40.1–53.2)
fMRI Rest state; clinical maneuver
(pain exacerbation); heat
pain (affected leg)
rCBF at 3 T




BOLD at 3 T
Bolwerk et al6 CRPS I and II: hand
and foot
Germany 12 (5/7) 61.1 ± 11.1 15.5 (4–406)
Weeks
5.3 ± 2.1 12 (5/7) 60.9 ± 11 fMRI Resting state BOLD at 1.5 T
Liu et al47 Postherpetic
neuralgia
China 11 (11/0) 66.2 ± 5.5 8.4 ± 6.2 Months 8.3 ± 1 11 (11/0) 64 (56–73) fMRI Resting state rCBF at 3 T
Flodin et al25 Fibromyalgia Sweden 16 (0/16) 48.3 (25–64) 7.6 ± 3.8 Years NA 22 (0/22) 45.7 (20–63) fMRI Ankle, knee, and hand
tasks
BOLD at 3 T
He et al32 Temporo-mandibular
disorder
China 23 (9/14) 22.4 ± 3.6 14.8 ± 20.7
Months
NA 20 (9/11) 23.1 ± 2.4 fMRI Resting state BOLD at 3 T
Pijnenburg et al69 LBP Belgium 17 (6/11) 33.3 ± 7.9 9.8 ± 8.2 Years 2 ± 2 17 (5/12) 31.8 ± 8.2 fMRI Resting state BOLD at 3 T
Shanahan et al85 OA knee Australia 11 (6/5) 68.9 ± 6.4 NA 4.3 ± .8 7 (5/2) 64 ± 6.7 fMRI 15 Pressure stimuli (5
different pressure
intensities) on left thumb
BOLD at 3 T






Canada 20 (17/3) 39.4 ± 12 12.8 ± 10.1 Years NA 20 (17/3) 39.7 ± 12 fMRI Resting state BOLD at 3 T
Hotta et al37 CRPS I: hand Finland 13 (0/13) 44.7 ± 6.9 5.2 ± 3.9 Years 7.7 ± 1.7 13 (0/13) 44.1 ± 8.6 fMRI Viewing videos of hand
actions
BOLD at 3 T
Tian et al95 Trigeminal
neuropathic pain
China 20 (8/12) 52.6 ± 8.9 21.1 ± 16.2
Months
7.7 ± 1.6 22 (6/16) 52.2 ± 6.1 fMRI and
MRI
Resting state BOLD and DKI
analysis at 3 T
Van Velzen
et al102
CRPS: hand Netherland 19 (0/19) 48.1 ± 11.6 110.8 ± 110.5
Years
7.1 ± 1.5 19 (0/19) 49.4 ± 11.6 fMRI and
MRI
Resting state BOLD, VBM and DTI
analysis at 3 T
























CHRONIC PAIN PARTICIPANTS HEALTHY PARTICIPANTS
MODALITY STIMULI OUTCOME MEASURES
STUDY SIZE





Moayedi et al58 Temporomandibular
disorder
Canada 17 (0/17) 33.1 ± 11.9 9.8 ± 8.2 Years 4.3 ± 1.8 17 (0/17) 32.2 ± 10.1 MRI Resting state Cortical thickness
analysis at 3 T
Desouza et al19 Trigeminal
neuropathic pain
Canada 24 (9/15) 48.5 ± 12.7 6.3 ± 3 Years NA 24 (9/15) 47.6 ± 12.3 MRI Resting state Cortical thickness
analysis via 3 T
Maeda et al48 Carpal tunnel
syndrome
United States 28 (8/20) 48.1 ± 9.6 8.5 ± 9.1 Years 2.5 ± .8 (0–5) 28 (11/
17)
47.3 ± 9.9 MRI Resting state DTI analyses at 3 T
Wu et al110 Ankylosing
spondylitis,
neuropathic pain
Canada 17 (12/5) 34.4 ± 12.4 NA 6.1 ± 1.7 17 (12/5) 34.9 ± 10.1 MRI Resting state Cortical thickness
analysis at 3 T
Pleger et al70 CRPS I: hand Germany 20 (9/11) 41.8 ± 9.8 11.9 ± 14.3
Months
5.3 ± 2.4 20 (9/11) 41.6 ± 9.6 MRI Resting state VBM analysis (?) at
1.5 T
Ung et al100 LBP United States 47 (25/
22)
373. ± 12.2 8.6 ± 7.8 Years NA 47 (25/
22)
37.7 ± 7.8 MRI Resting state VBM (SVM) analysis
at 3 T
Juottonen et al39 CRPS I: hand Finland 6 (0/6) 44.5 (33–54) 42.2 ± 26.2
Months
































Jacobs et al38 LBP United States 10 (5/5) 39.2 ± 6.3
(95% CI)




Shiraishi et al88 CRPS Japan 18 (10/8) 40.7 (21–59) 49.8 (6–252)
Months
NA 13 (11/2) 38.7 (27–58) PET Resting state Cerebral glucose
metabolism
Abbreviations: M, male; F, female; NA, not available; SEM, standard error of the mean; DKI, diffusion kurtosis imaging; DTI, diffusion tensor imaging; SVM, support vector machine.















Table 4. Risk of Bias Assessment for Included Studies
REFERENCE









Salerno et al75 0 1 0 0 1 2 41.4% 39.3%
Schwenkreis et al81 0 1 1 1 0 3 64.3% 63%
Strutton et al91 1 0 0 1 1 3 40% 41.7%
On et al63 0 1 0 1 0 2 53.8% 52%
Eisenberg et al21 1 1 1 1 0 4 72.4% 71.4%
Krause et al43 0 0 0 1 0 1 61.5% 48%
Strutton et al92 1 0 0 1 1 3 52% 45.8%
Krause et al44 1 0 0 1 0 2 52% 37.5%
Turton et al99 0 1 0 1 1 3 46.2% 44%
Tsao et al97 0 1 1 1 1 4 73.1% 76%
Berth et al5 0 0 1 1 1 3 77% 68%
Turgut et al98 0 1 1 1 0 3 69.2% 64%
Mhalla et al57 1 1 0 1 0 3 55.2% 53.6%
Schwenkreis et al82 0 1 1 1 1 4 64.3% 66.7%
Clark et al15 0 1 0 1 1 3 54.2% 52.2%
Schwenkreis et al83 0 0 0 1 1 2 64.3% 55.6%
Tsao et al96 0 0 1 1 1 3 79.2% 82.6%
Masse-Alarie et al54 0 0 1 1 1 3 69% 71.4%
Vallence et al105 0 0 1 0 1 2 77% 68%
Kittelson et al41 0 1 1 1 1 4 72.4% 71.4%
Marker et al51 1 0 1 1 1 4 90% 82.1%
Rittig-Rasmussen et al73 1 1 0 1 1 4 57.7% 56%
Bradman et al7 0 0 0 1 1 2 61.5% 52%
Schabrun et al78 0 1 0 1 1 3 43.5% 43.5%
Schabrun et al79 1 1 1 1 1 5 77% 76%
Van Velzen et al101 1 1 0 0 1 3 57.7% 52%
Burns et al8 0 1 1 1 1 4 79.3% 75%
Caumo et al11 1 0 0 1 1 3 62.1% 46.4%
Masse-Alarie et al52 0 1 0 1 1 3 62.1% 59.3%
Masse-Alarie et al53 0 1 1 1 1 4 69% 64.3%
Rio et al72 1 1 0 1 0 3 57.7% 60%
Tarrago et al93 1 1 0 1 1 4 69% 55.6%
Morgante et al60 0 1 1 1 1 4 72.4% 77.8%
Parker et al66 0 1 1 1 1 4 96.6% 88.9%
Te et al94 1 1 1 1 1 5 75% 79.2%
Grachev et al29 0 1 1 1 1 4 NA NA
Juottonen et al39 0 1 1 0 1 3 NA NA
Cook et al17 0 0 0 0 1 1 NA NA
Napadow et al62 0 1 1 1 1 4 NA NA
Shiraishi et al88 0 1 1 0 0 2 NA NA
Maihöfner et al49 0 1 1 0 1 3 NA NA
Shibukawa et al87 0 1 1 1 1 4 NA NA
Gieteling et al28 0 1 1 0 1 3 NA NA
Kobayashi et al42 0 0 1 0 1 2 NA NA
Fayed et al23 1 0 0 1 1 3 NA NA
Jacobs et al38 0 0 1 1 1 3 NA NA
Kirveskari et al40 0 0 1 1 1 3 NA NA
Moayedi et al58 0 1 0 1 1 3 NA NA
Wasan et al108 0 1 0 0 1 2 NA NA
Barke et al4 1 1 0 1 0 3 NA NA
Sharma et al86 0 1 1 1 1 4 NA NA
Bolwerk et al6 0 1 1 1 1 4 NA NA
Desouza et al19 0 1 0 1 1 3 NA NA
Liu et al47 0 1 0 0 1 2 NA NA
Maeda et al48 0 1 0 1 1 3 NA NA
Wu et al110 0 1 0 1 1 3 NA NA
Flodin et al25 1 1 1 1 1 5 NA NA
He et al32 0 1 1 0 1 3 NA NA
(continued on next page)
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trigeminal neuralgia19 (n = 48 participants, quality
score = 3), and larger left M1 cortical thickness that were
associated with stronger neuropathic pain symptoms in
ankylosing spondylitis110 (r = .8, n = 34 participants, quality
score = 3). One diffusion tensor imaging study reported
that enhanced myelination (lower radial diffusivity) in the
microstructure of white matter connecting primary sensory
cortex and M1 contralateral to the affected side was cor-
related with nerve conduction velocity in carpal tunnel
syndrome48 (r = .72, n = 56 participants, quality score = 3).
In LBP, 1 MRI study reported increased M1 gray matter
(GM) density in people with chronic LBP100 (P < .001 un-
corrected for multiple comparisons, n = 94 participants,
quality score = 2). Although 1 study reported decreased
functional connectivity in the left M1, the left supple-
mentary motor area, and the left cerebellum compared
with healthy participants69 (1.88 ± 0.89 SD vs 2.64 ± 0.8
SD, n = 34 participants, quality score = 2), the other re-
ported increased rCBF in the left M1108 (cluster-level P < .01,
n = 32 participants, quality score = 2). Two studies re-
ported no change in M1 activation/connectivity using
BOLD contrast (n = 45 participants, quality score = 3,42 and
n = 16 participants, quality score = 24). One EEG study re-
ported altered cerebrocortical motor activity before an
arm raise in chronic LBP participants38 (n = 20 partici-
pants, quality score = 3). MRS studies reported conflicting
findings for M1 neurochemical metabolism. One study
reported no between group difference in sensorimotor
cortex29 (n = 20 participants, quality score = 4), whereas
the other reported lower N-acetylasparate concentra-
tions in the right M1 compared with healthy participants86
(9 ± .9 mM vs 10.2 ± 1.2 mM, n = 33 participants, quality
score = 4). For ankylosing spondylitis-related back pain,
greater functional impairment was correlated with greater
M1–precuneous resting functional connectivity and im-
paired spinal mobility was associated with weaker M1–
rostral ventromedial medulla functional connectivity on
BOLD contrast34 (n = 40 participants, quality score = 2).
Findings in people with CRPS were inconsistent for M1
structure from VBM studies. One study showed in-
creased M1 GM density70 (cluster-level P = .042, corrected,
n = 40 participants, quality score = 2), whereas the other
showed no between group difference in GM volume and
white matter connectivity in sensorimotor cortex102 (n = 38
participants, quality score = 3). Similarly, findings for M1
activation/connectivity from BOLD contrast were incon-
sistent. Two studies showed increased activation in
bilateral M149 (cluster-level P < .0001, uncorrected, n = 24
participants, quality score = 3) or connectivity6 (cluster-
level P < .01, corrected, n = 24 participants, quality
score = 4), whereas 2 showed no changes compared with
healthy participants (n = 25 participants, quality score = 3,28
and n = 38 participants, quality score = 3102). There was
a significant between group difference in activation of
the sensorimotor cortex37 (P < .05, corrected, n = 26 par-
ticipants, quality score = 3).
In temporomandibular disorder (TMD), 1 VBM study
reported that greater pain severity was associated with
smaller GM thickness of the M1 region where the rep-
resentation of the face was situated58 (r = −.83, n = 34
participants, quality score = 3). BOLD contrast showed de-
creased intrinsic neural activity in the left M1 in individuals
with TMD32 (P < .05, corrected, n = 43 participants, quality
score = 3). One MEG study reported that TMD partici-
pants had significantly smaller neuromagnetic signals in
M1 during observation of jaw-opening movements87 (1 ± 1
nano amp meter vs 16 ± 3 nano amp meter, n = 17 par-
ticipants, quality score = 4).
In fibromyalgia, 1 MRS study showed a lower myoi-
nositol to creatine ratio in the left sensorimotor cortex,
indicating possible M1 neuronal metabolic dysfunction23
(P < .05, n = 20 participants, quality score = 3). Two studies
using BOLD contrast reported conflicting findings in M1
activation/connectivity. One reported no between group
difference17 (n = 18 participants, quality score = 3), whereas
the other showed decreased sensorimotor cortex
connectivity25 (P < .00031, corrected, n = 38 partici-
pants, quality score = 4).
One fMRI study in people with knee OA reported that
the M1 representation of the affected knee was shifted
4.1 mm anteriorly (SD or CI not reported) and the rela-
tive position of the knee and ankle representations were
swapped when participants performed ankle and knee
tasks85 (n = 18 participants, quality score = 2). In
Table 4. Continued
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Pleger et al70 0 1 0 0 1 2 NA NA
Ung et al100 0 1 0 0 1 2 NA NA
Pijnenburg et al69 0 1 0 0 1 2 NA NA
Shanahan et al85 0 1 0 0 1 2 NA NA
Flodin et al24 1 1 1 0 1 4 NA NA
Hemington et al34 0 1 0 0 1 2 NA NA
Hotta et al37 1 1 0 0 1 3 NA NA
Tian et al95 1 0 1 1 1 4 NA NA
Van Velzen et al102 0 1 0 1 1 3 NA NA
Abbreviations: STROBE, STrengthening the Reporting of OBservational studies in Epidemiology; NA not available.
NOTE: Each domain would be allocated 1 point if the risk of bias was low and zero point if the risk of bias was considered high. The maximum score possible was
five points. NA: not applicable.
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addition, poorer performance of a knee task was asso-
ciated with more anterior placement of the M1 loci in
people with knee OA. In rheumatoid arthritis, 1 study
using BOLD contrast reported increased connectivity of
bilateral sensorimotor cortex with the supplementary
motor and midcingulate cortex24 (P < .00031, corrected,
n = 43 participants, quality score = 4).
Is There Evidence of Altered
Corticospinal Excitability in Chronic Pain?
Data for resting motor threshold, aMT, MEP ampli-
tude and latency, CSP, and map volume were pooled to
perform separate meta-analyses from studies using single-
pulse TMS. Pooled effect estimates for all measures
revealed no difference between people with and without
pain (Table 5; Supplementary Figs 1–6). There was sub-
stantial heterogeneity across all measures with the
exception of MEP latency and map volume of erector
spinae.
For comparisons in which significant heterogeneity was
observed, we conducted subgroup analysis according to
condition. A moderate reduction in aMT in people with
chronic knee pain (3 studies, 73 participants, SMD = −.52,
95% CI = −1.02 to −.02, P = .04, χ2 P = .68, I2 = 0%; all
studies have quality score >3; Supplementary Fig 2) was
detected, indicating increased M1 corticospinal excitability.
Seven of 35 TMS studies7,43,44,63,75,83,105 scored lower than
3 (median value) on the modified STROBE statement and
were categorized as high risk of bias. Meta-analyses rerun
after removing the high risk of bias TMS studies
detected a large reduction in the CSP for CRPS but left
only a single small study (n = 20 participants) in that
subgroup.
Is There Evidence for Altered Intra-
Cortical Facilitation and/or Inhibition in
Chronic Pain?
Sixteen studies investigated intracortical inhibitory and
facilitatory networks using paired-pulse TMS para-
digms with several different measures. A moderate
increase in long-interval intracortical inhibition (LICI) was
detected in people with pain (3 studies, 102 partici-
pants, SMD = .78, 95% CI = .37–1.19, P < .001, χ2 P = .84,
I2 = 0%; Fig 2), indicating increased M1 intracortical in-
hibition. No difference between people with and without
pain was found for short-interval intracortical inhibi-
tion (SICI), intra-cortical facilitation (ICF) or short-
interval ICF (SICF; Table 5, Supplementary Figs 7–9). One
study appeared to mislabel ICF as SICF on the basis of the
experimental protocol and was not included in the
meta-analysis.11 There was substantial heterogeneity in
the pooled effect estimates for SICI (χ2 P < .01, I2 = 80%)
and ICF (χ2 P = .04, I2 = 51%). The subgroup analysis
showed a moderate reduction in SICI in people with CRPS
(4 studies, 100 participants, SMD = −.77, 95% CI = −1.21
to −.34, P < .01, χ2 P = .72, I2 = 0%; Supplementary Fig 7),
indicating reduced M1 intracortical inhibition, and a mod-
erate reduction in ICF in people with non-neuropathic
Table 5. Effect Sizes for Between Group Differences (People With and Without Pain) From Meta-
Analyses of TMS Studies. Pooled Estimates for All Measures Revealed No Difference Between
People With and Without Pain, With the Exception of LICI
OUTCOME MEASURE NUMBER OF INCLUDED STUDIES NUMBER OF PARTICIPANTS
QUALITY SCORE RANGE
(MAXIMUM SCORE = 5) SMD (95% CI)
Resting motor threshold 19 604 1 to 5 .01 (−.29 to .31)
AMT 12 357 3 to 5 .11 (−.24 to .46)
MEP amplitude 24 788 1 to 5 −.15 (−.38 to .09)
MEP latency 4 181 2 to 4 .21 (−.11 to .52)
Cortical silent period 12 481 1 to 4 −42 (−.85 to .00)
Map volume: erector spinae 2 70 3 −.24 (−.72 to .23)
Map volume: wrist extensor 2 46 2 to 5 .35 (−.66 to 1.36)
SICI 15 572 2 to 4 .07 (−.36 to .50)
LICI 3 102 2 to 4 .78 (.37–1.19)
ICF 7 249 2 to 4 −.26 (−.65 to .14)
SICF 3 113 3 to 4 .23 (−.24 to .70)
Figure 2. Meta-analysis forest plot for LICI.
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pain (6 studies, 151 participants, SMD = −.53, 95% CI =
−.94 to −.13, P = .01, χ2 P = .24, I2 = 26%; Supplementary
Fig 8), indicating reduced M1 ICF.
Evidence of reduced M1 intracortical inhibition in
people with CRPS is complemented by the findings of at-
tenuated activities of the 20-Hz cortical rhythm (which
reflects decreased M1 cortical inhibition) from 2 MEG
studies. The 20-Hz rebound duration in the right hemi-
sphere was significantly shorter39 (357 vs 458 ms, P < .03,
n = 18 participants, quality score = 3), and the rebound
amplitude (1 ± 1 SD vs 7 ± 3 SD femtotesla/cm, P = .05) and
the reactivity (4 ± 2 SD vs 16 ± 5 SD femtotesla/cm, P = .03)
to painful hand stimuli were significantly smaller40 (n = 18
participants, quality score = 3) compared with healthy par-
ticipants. One PET study (n = 31 participants, quality
score = 2) showed reduced glucose metabolism in the con-
tralateral M1 in CRPS88 (P < .005, uncorrected), suggesting
possible M1 inhibition.
Discussion
To our knowledge, this systematic review is the first
to provide a comprehensive and critical review of studies
investigating M1 structure, organization, and function
in people with chronic pain. For a range of neurophysi-
ological parameters, published studies provided conflicting
evidence. Meta-analyses identified a moderate increase
in M1 LICI in people with chronic pain. Our findings
suggest that the evidence for M1 changes in chronic pain
populations is inconclusive for most measures.
Evidence for Altered ICF and/or
Inhibition in Chronic Pain
Pooled data from 3 studies investigating non-
neuropathic pain provided evidence of increased LICI,
indicating increased M1 intracortical inhibition. In-
creased LICI reflects upregulated γ-aminobutyric acid
(GABA)B-mediated intracortical inhibition.55 Subgroup
analyses showed reduced ICF in non-neuropathic pain,
suggesting decreased ICF of glutamatergic interneu-
rons through N-methyl-D-aspartate receptors,111 and
reduced SICI in CRPS, suggesting M1 intracortical disin-
hibition driven by downregulated GABAA-receptors.55,109
However, although our subgroup analyses were
preplanned, interpretation of these findings requires
caution because there are no overall effects in the pooled
estimates for SICI and ICF.
Consistent with a previous review of CRPS,20 our review
also found M1 disinhibition on the basis of MEG out-
comes from 2 studies. The 20-Hz cortical rhythm measured
in MEG is initially decreased (suppression; reflecting an
activated M1) and subsequently increased (rebound; re-
flecting inhibited M1) and represents the functional state
of M1.68,76 Combined MEG and MRS showed a positive
correlation between 20-Hz rebound amplitude and the
concentration of the inhibitory neurotransmitter GABA,
indicating the rebound period represents GABAergic in-
hibition in M1.27 MEG studies reported a significantly
shorter rebound duration of 20-Hz rhythm in both
hemispheres,39 and weaker rebound amplitude and re-
activity of 20-Hz rhythm in the hemisphere contralateral
to the affected side,40 indicating M1 disinhibition in CRPS.
These findings suggest M1 disinhibition in CRPS, reflect-
ing downregulated GABAergic inhibition. The MEG
findings of reduced M1 inhibition in CRPS are inconsis-
tent with the findings of increased LICI in chronic pain
from TMS studies. These inconsistencies could be ex-
plained because none of these TMS studies investigated
CRPS. Although 1 PET study reported reduced glucose me-
tabolism in the contralateral M1 for CRPS in the group
analysis, indicating possible M1 inhibition, only 3 (of 18)
CRPS participants showed this finding in the individual
analysis.88 Future larger trials are needed to elucidate M1
glucose metabolism in CRPS.
Evidence of Altered M1 Structure,
Organization, and Function in Chronic
Pain
There is conflicting evidence for M1 changes in chronic
pain, which may be explained by the heterogeneity of
the underlying neurophysiological mechanisms, meth-
odological differences, internal study biases, reporting
biases, and the random play of chance, because of the
small sample sizes of the included studies. For example,
heterogeneity of underlying neurophysiological mecha-
nisms in nonspecific chronic LBP has been reported.89 A
mixture of neuropathic and non-neuropathic pain com-
ponents were identified not only in chronic nonspecific
LBP,90 but ankylosing spondylitis back pain,110 and knee
and hip OA.26,36,59,61 However, it is unclear whether a neu-
ropathic pain subgroup exists in other pain conditions.
Future studies should investigate whether distinct pain
subgroups exist within chronic pain conditions and
whether these subgroups present with different M1
changes.
Evidence from several different measures suggests in-
creased M1 activation/connectivity in neuropathic pain.
M1 disinhibition has been attributed to increased M1 ac-
tivation (carpal tunnel syndrome), increased M1 rCBF
(postherpic neuralgia), and increased M1 functional con-
nectivity (trigeminal neuralgia)47,62,95 though M1
disinhibition in neuropathic pain was not supported by
the finding of a reduction in MEP amplitude from a single
study in people with diabetic neuropathy98
(Supplementary Fig 3). More research is needed to elu-
cidate the neurophysiological mechanisms driving M1
functional changes in neuropathic pain populations.
Several studies reported that impaired motor control
in chronic pain was associated with M1 reorganization
or altered corticomotor physiology.38,85,97 For example,
delayed activation of the trunk muscles when perform-
ing an arm raise in chronic LBP patients was associated
with smaller amplitudes of Bereitschafts potential, an EEG
potential generated by M1 and the supplementary motor
cortex representing movement preparation,38 and with
increased map volume and the posterolaterally shifted
M1 representation of transversus abdominis.97 This sup-
ports the role of altered M1 in motor control impairment
in musculoskeletal disorders. However, the causal rela-
tionship and the interaction between M1 changes, motor
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control impairment, and symptom persistence in chronic
pain requires further investigation.
A previous review on M1 function in CRPS could not
draw a definite conclusion on M1 functional changes.20
Two recent MRI studies investigating M1 function and
structure for CRPS were included in this review, which
reported conflicting findings, likely because of differ-
ent experimental protocols (resting state vs observational
tasks).37,102 Taken together with the other neurophysi-
ological evidence, no conclusion on M1 changes in CRPS
can be drawn from our findings.
Evidence of Altered Corticospinal
Excitability in Chronic Pain
Meta-analyses of TMS data revealed no significant
change in any measure of corticospinal excitability in
people with chronic pain. Although subgroup analysis
found a reduction in aMT in chronic knee pain, suggest-
ing increased excitability in the motor system particularly
in relation to neuronal and interneuronal membrane
excitability,112 interpretation of this finding requires
caution because there is no overall effect in the pooled
estimate for aMT.
A previous review on corticomotor excitability in chronic
pain reported evidence of M1 disinhibition that was more
prominent in neuropathic pain populations.65 However,
our review did not find compelling evidence of M1 dis-
inhibition when people with and without pain were
compared. This discrepancy is likely because of our in-
clusion of more recent studies7,11,52,53,60,66,72,79,85,93,94 and
exclusion of studies containing neurological populations.45
Also, CRPS studies were separated from neuropathic pain
in our subgroup analyses because they have different di-
agnostic criteria and pathophysiology.
Altered M1 representation of erector spinae muscles
(reduced map volume) in chronic LBP has been reported,96
but not supported by a larger study.78 Pooled map
volume data from these studies found no significant
difference between LBP and healthy participants. The
differences between the studies in sample size and
methodology such as different electromyography elec-
trodes (fine wire needle vs superficial, surface electrodes),
the sizes of grid used to measure the map (5 × 7 cm
versus 6 × 7 cm), and different coils used to deliver TMS
could contribute to the contradictory findings of M1
reorganization of erector spinae in LBP. Although some
small single studies reported increased map volume of
the wrist extensor (lateral epicondylalgia) and transver-
sus abdominis (LBP) muscles, and decreased map volume
of quadriceps (patellofemoral pain; Supplementary Fig 5),
meta-analyses do not support the changes in M1
representations.
Limitations and Recommendations
Several limitations should be considered when inter-
preting the findings of this review. First, most included
studies were small, and may be affected by low statis-
tical power as well as conversely, the propensity for small
published studies to return positive and often inflated
effect sizes.10 Additionally, subgroup analyses are re-
garded as exploratory and interpretation of these findings
requires caution, particularly when there is no overall
effect in the pooled estimates. False positive signifi-
cance tests also increase in likelihood rapidly as more
subgroup analyses are performed.
TMS studies investigating M1 representations of the
affected muscles in chronic pain reported the center of
gravity (CoG) as the location of M1 representation.
Smudged M1 representations of affected muscles (mea-
sured by the distance between the CoG of neighboring
muscles) has been reported in chronic LBP and lateral
epicondylalgia, suggesting M1 reorganization.78,79,96
However, we were unable to meta-analyze CoG data
because studies reported either the coordinates of the
CoG or the absolute distance between the averaged
CoG for each group. Future research using TMS to
investigate M1 representation of the affected muscles
should report the coordinates of CoG for meta-analysis
of the data. We also acknowledge that 4 included TMS
studies were published by 1 of the coauthors of this
review.8,78,79,94 To minimize the bias, reviewers who
were not involved in these studies performed the risk
of bias assessment.
A recent study reported that the errors of software
commonly used for data analysis in fMRI studies may
result in a false positive rate of up to 70% and ques-
tioned the validity of some fMRI studies.22 It is beyond
the scope of this review to discuss how these statistical
issues may influence the findings of this review. However,
the fMRI findings of M1 activation/connectivity and
organization for chronic pain in this review should be
interpreted with caution. Several studies included in
this review investigated the sensorimotor cortex rather
than the M1.23-25,37,102 It is possible that heterogeneity in
the brain region being investigated (ie, sensorimotor vs
M1) contributed to the inconclusive findings of this
review.
Conclusions
This review provides the current evidence on M1 struc-
ture, organization, and function in chronic pain and
identifies areas where further research is required. EEG,
MEG, MRS, and PET techniques have been rarely used to
investigate M1 function in chronic pain. Data pertain-
ing to M1 changes for conditions such as TMD,
rheumatoid arthritis, neck, shoulder, and neuropathic pain
are still lacking. Additionally, more research using paired-
pulse TMS paradigms to investigate M1 ICF/and inhibition
in chronic pain is required because data are still lacking
for measures of LICI and SICF. Future studies with larger
sample sizes are warranted to elucidate M1 changes in
chronic pain conditions and to inform treatments tar-
geting M1.
Supplementary Data
Supplementary data related to this article can be found
at https://doi.org/10.1016/j.jpain.2017.10.007.
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